These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3359427)

  • 1. Quantification of urinary mutagens in nurses during potential antineoplastic agent exposure. A pilot study with concurrent environmental and dietary control.
    Caudell KA; Vredevoe DL; Dietrich MF; Caudell TP; Hoban MJ; Block JB
    Cancer Nurs; 1988 Feb; 11(1):41-50. PubMed ID: 3359427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mutagenic substances in the urine of nurses in an oncological department].
    Rørth M; Jørgensen J; Jørgensen V; Knudsen I; Larsen JC; Munck F
    Ugeskr Laeger; 1983 Feb; 145(7):475-8. PubMed ID: 6845511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pregnancy in health care personnel handling cancer medications].
    Hemminki K; Kyyrönen P; Lindbohm ML; Selevan SG
    Katilolehti; 1986 Jun; 91(4):158-67. PubMed ID: 3640895
    [No Abstract]   [Full Text] [Related]  

  • 4. [The possible mutagenic effect of cytostatics on nurses at an oncologic department].
    Larsen H; Madsen ES
    Ugeskr Laeger; 1984 Oct; 146(41):3135-7. PubMed ID: 6515952
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutagenicity in urine of nurses handling cytostatic drugs.
    Falck K; Gröhn P; Sorsa M; Vainio H; Heinonen E; Holsti LR
    Lancet; 1979 Jun; 1(8128):1250-1. PubMed ID: 87722
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
    Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of urine mutagenicity of pharmacy personnel exposed to antineoplastic agents.
    Connor TH; Theiss JC; Anderson RW; Puckett WH; Matney TS
    Am J Hosp Pharm; 1986 May; 43(5):1236-9. PubMed ID: 3521267
    [No Abstract]   [Full Text] [Related]  

  • 8. Work environment influence on cytostatics-induced genotoxicity in oncologic nurses.
    Brumen V; Horvat D
    Am J Ind Med; 1996 Jul; 30(1):67-71. PubMed ID: 8837685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncology nurses' awareness of cognitive impairment secondary to chemotherapy.
    Myers JS; Teel C
    Clin J Oncol Nurs; 2008 Oct; 12(5):725-9. PubMed ID: 18842529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational exposure of nursing personnel to antineoplastic agents.
    Cloak MM; Connor TH; Stevens KR; Theiss JC; Alt JM; Matney TS; Anderson RW
    Oncol Nurs Forum; 1985; 12(5):33-9. PubMed ID: 3898029
    [No Abstract]   [Full Text] [Related]  

  • 11. Reproductive risks associated with exposure to antineoplastic agents: a review of the literature.
    Hoffman DM
    Hosp Pharm; 1986 Oct; 21(10):930-2, 936, 940. PubMed ID: 10301074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary exposure from pesticide application on farms in the Agricultural Health Pilot Study.
    Melnyk LJ; Berry MR; Sheldon LS
    J Expo Anal Environ Epidemiol; 1997; 7(1):61-80. PubMed ID: 9076610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An investigation on the chromosomal damage in nurses occupationally exposed to antineoplastic drugs].
    Xu SJ; Wang JX; Yang DP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):119-20. PubMed ID: 12839665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemotherapeutic agents as occupational hazards: a literature review.
    Stellman JM; Zoloth SR
    Cancer Invest; 1986; 4(2):127-35. PubMed ID: 3518876
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective measures used by oncologic office nurses handling parenteral antineoplastic agents.
    Stajicj GV; Barnett CW; Turner SV; Henderson CA
    Oncol Nurs Forum; 1986; 13(6):47-9. PubMed ID: 3642563
    [No Abstract]   [Full Text] [Related]  

  • 16. Menstrual cycles in nurses handling antineoplastic drugs.
    Shortridge LA; Lemasters GK; Valanis B; Hertzberg V
    Cancer Nurs; 1995 Dec; 18(6):439-44. PubMed ID: 8564939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety for the handling of cytostatic substances. Protective measures are useful].
    Schmid B
    Krankenpfl Soins Infirm; 1985 Jul; 78(7):39-41, 66-8. PubMed ID: 3850203
    [No Abstract]   [Full Text] [Related]  

  • 18. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.
    Rekhadevi PV; Sailaja N; Chandrasekhar M; Mahboob M; Rahman MF; Grover P
    Mutagenesis; 2007 Nov; 22(6):395-401. PubMed ID: 17855733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How do we handle cytostatics?].
    Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(4):748-50. PubMed ID: 3915152
    [No Abstract]   [Full Text] [Related]  

  • 20. Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs.
    Tuffnell PG; Gannon MT; Dong A; DeBoer G; Erlichman C
    Am J Hosp Pharm; 1986 Feb; 43(2):344-8. PubMed ID: 3513557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.